Papers: 10.3390/jcm9103213

https://doi.org/10.3390/jcm9103213

One Year’s Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial

Cited by: 13
Author(s): Louise Vedtofte, Emilie Bahne, Signe Foghsgaard, Jonatan I. Bagger, Camilla Andreasen, Charlotte Strandberg, Peter Michael Gørtz, Jens J. Holst, Henning Grønbæk, Jens Svare, Tine D. Clausen, Elisabeth R. Mathiesen, Peter Damm, Lise Lotte Gluud, Filip K. Knop, Tina Vilsbøll
Published: almost 6 years ago

Software Mentions 1